Efficus Life Sciences And Pharmaceuticals Private Limited

Pharmaceutical company manufacturing and marketing various products, based in Kerala.

2017 | Thiruvananthapuram, Kerala (India) | Active
Last Updated: January 03, 2025

Efficus Life Sciences And Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.80 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 9.50 M
  • Satisfied Charges ₹ 0.69 M
  • Revenue Growth -35.00%
  • Profit Growth -93.53%
  • Ebitda -1140.41%
  • Net Worth 1.66%
  • Total Assets 8.40%

About Efficus Life Sciences And Pharmaceuticals

Efficus Life Sciences And Pharmaceuticals Private Limited (ELSAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2017 (Seven years and 11 months 2 days old ). Its registered office is in Thiruvananthapuram, Kerala, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M.

The company currently has active open charges totaling ₹9.50 M. The company has closed loans amounting to ₹0.69 M, as per Ministry of Corporate Affairs (MCA) records.

Chavercode Rose, Sajith Kamalasanan, Kamalasanan Ajith, and Two other members serve as directors at the Company.

Company Details

  • Location

    Thiruvananthapuram, Kerala, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24304KL2017PTC048683

  • Company No.

    048683

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    24 Mar 2017

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ernakulam

Industry

Pharma

Who are the key members and board of directors at Efficus Life Sciences And Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Kamalasanan Ajith Country flag representing In Managing Director24-Mar-2017Current

Board Members (4)

NameDesignationAppointment DateStatus
Chavercode Rose Country flag representing In Director 24-Mar-2017Current
Sajith Kamalasanan Country flag representing In Director 06-Apr-2017Current
Rema Vidyadharan Country flag representing In Director 26-Sep-2017Current
Chavercode Honey Country flag representing In Director 06-Apr-2017Current

Financial Performance of Efficus Life Sciences And Pharmaceuticals.

Efficus Life Sciences And Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 35% decrease. The company also saw a substantial fall in profitability, with a 93.53% decrease in profit. The company's net worth moved up by a moderate rise of 1.66%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-35.00%
Revenue from Operations
-48.47%
Total Assets
8.40%
Profit or Loss
-93.53%
Net Worth
1.66%
EBITDA
-1140.41%

What is the Ownership and Shareholding Structure of Efficus Life Sciences And Pharmaceuticals?

In 2021, Efficus Life Sciences And Pharmaceuticals had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹9.50 M

Satisfied Charges

₹0.69 M

Charges Breakdown by Lending Institutions

  • Others : 0.95 Cr

Latest Charge Details

DateLenderAmountStatus
25 Nov 2019Others₹8.50 MOpen
30 Jan 2018Others₹1.00 MOpen
19 Jun 2020Others₹0.69 MSatisfied

How Many Employees Work at Efficus Life Sciences And Pharmaceuticals?

Unlock and access historical data on people associated with Efficus Life Sciences And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Efficus Life Sciences And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Efficus Life Sciences And Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Efficus Life Sciences And Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Efficus Life Sciences And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Efficus Life Sciences And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.

    31 Mar 2024

  • Charges

    A charge registered on 19 Jun 2020 via Charge ID 100354725 with Others was fully satisfied on 14 Mar 2022.

    14 Mar 2022

  • Charges

    A charge with Others of Rs. 8.50 M registered on 25 Nov 2019 with Charge ID 100310337 was modified on 30 Apr 2021.

    30 Apr 2021

  • Charges

    A charge with Others amounted to Rs. 0.69 M with Charge ID 100354725 was registered on 19 Jun 2020.

    19 Jun 2020

  • Charges

    A charge with Others amounted to Rs. 8.50 M with Charge ID 100310337 was registered on 25 Nov 2019.

    25 Nov 2019

Frequently asked questions

  • Efficus Life Sciences And Pharmaceuticals Private Limited was incorporated on 24 Mar 2017.

  • The authorized share capital of Efficus Life Sciences And Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.80 M.

  • Currently 5 directors are associated with Efficus Life Sciences And Pharmaceuticals Private Limited.

    • Chavercode Madhu Rose
    • Sajith Kamalasanan
    • Kamalasanan Ajith
    • Rema Vidyadharan
    • Chavercode Madhu Honey
  • As per Ministry of Corporate Affairs (Mca), the registered address of Efficus Life Sciences And Pharmaceuticals Private Limited is Tc:11/992-17 Temple Road Parottukonam, Nalanchira P O India, Trivandrum, Kerala, 695015.

  • The corporate identification number (CIN) of Efficus Life Sciences And Pharmaceuticals Private Limited is U24304KL2017PTC048683 and the company number is 048683 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2021, the revenue trend for Efficus Life Sciences And Pharmaceuticals Private Limited has fallen by -35.00%.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Efficus Life Sciences And Pharmaceuticals Private Limited has experienced an upsurge of 1.66%.

  • As per the financial statements for fiscal Year 2021, The total open charges for Efficus Life Sciences And Pharmaceuticals Private Limited amount to ₹ 9.50 M.

  • The most recent Balance Sheet for Efficus Life Sciences And Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development